ULLANESSE cpr pell 30 mg

7680683720018 CH-68372 G03AD02 09.02.1.
ULLANESSE cpr pell 30 mg
ULLANESSE cpr pell 30 mg
ULLANESSE cpr pell 30 mg
1 / 3
google

Details

Product number
6837201
CPT
-
Packaging group
1
Unit
Tablette(n)
Composition
ulipristalii acetas 30 mg, lactosum monohydricum 240 mg, amylum pregelificatum, carboxymethylamylum natricum A corresp. natrium 1 mg, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, acidum stearicum, talcum, E 171, pro compresso obducto.

Articles (1)

Ullanesse 30mg, Filmtabletten
Filmtabletten
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/04/2025
Patient information leaflet
Français
10/04/2025
Patient information leaflet
Italien
10/04/2025
Professional SmPC
Allemand
10/04/2025
Professional SmPC
Français
10/04/2025
Professional SmPC
Italien
10/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
240.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68372
Drug name
Ullanesse, Filmtabletten
Galenic form
FILM
ATC Code
G03AD02
Authorization status
Z
Dispensation category
B
First authorization
21/12/2022
Authorization expiration date
20/12/2027
IT number
09.02.1.
Domain
Human medicine
Field of application
Notfallkontrazeption innerhalb von 5 Tagen

Packaging details

Description (FR)
ULLANESSE cpr pell 30 mg
Description (DE)
ULLANESSE Filmtabl 30 mg
Market launch
21/12/2022
Narcotic (BTM)
No